Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study

NCT02840708 is registered in ClinicalTrials.gov with Niigata University Medical & Dental Hospital as lead sponsor.

NCT NCT02840708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02840708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study
Lead sponsor
Niigata University Medical & Dental Hospital
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2016
Completion date
September 1, 2017
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary alveolar proteinosis, autoimmune